Trials / Conditions / Multiple Myeloma Stage I
Multiple Myeloma Stage I
3 registered clinical trials studyying Multiple Myeloma Stage I.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma NCT03428373 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 2 / Phase 3 |
| Unknown | Daratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation NCT03792620 | Grupo de Estudos Multicentricos em Onco-Hematologia | Phase 3 |
| Terminated | Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I NCT00171925 | Novartis Pharmaceuticals | Phase 3 |